Pax Neuroscience
PrivateLast Round
Grant
Jan 1, 2022
Total Funding Raised
$1.57M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Pax Neuroscience is a biotechnology company that develops protein biomarker-based clinical laboratory services for the diagnosis and treatment of depression.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Mental Health, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pax Neuroscience Comparables
Compare Pax Neuroscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MindX Sciences | 81% | |
| Circular Genomics | 79% | |
| Atlantic Diagnostic Laboratories | 77% |
Pax Neuroscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2022 | ||||
| Grant | Sep 4, 2013 |
Key People
Founding team and executive leadership
Pax Neuroscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Mental Health | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 135% MoM.
- May 3, 2025
Monthly visitors increased 114% MoM.
Pax Neuroscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pax Neuroscience's valuation, stock price, and market status.
Is Pax Neuroscience a public or private company?
Pax Neuroscience is a private company.
What is the current stock price of Pax Neuroscience?
Pax Neuroscience is a private company with no public stock price. No recent secondary market data is available.
How much is Pax Neuroscience worth (valuation)?
Valuation information for Pax Neuroscience is not publicly available.
Can I buy Pax Neuroscience stock?
Pax Neuroscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pax Neuroscience's last funding round?
Pax Neuroscience's most recent funding round was Grant on January 1, 2022.
Who are the main investors in Pax Neuroscience?
Key investors in Pax Neuroscience include National Institute of Mental Health.
Will Pax Neuroscience IPO soon?
No public IPO plans have been announced for Pax Neuroscience.
How can I track Pax Neuroscience secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pax Neuroscience's secondary market activity and sign up for updates.